Late Breaking Abstract - Prevalence and clinical significance of antinuclear antibody (ANA) in IPF: analysis from ESTAIR study

P. Wung (Bridgewater, United States of America), G. Raghu (Seattle, United States of America), B. Crestani (Paris, France), L. Richeldi (Rome, Italy), C. Esperet (Paris, France), C. Soubrane (Paris, France)

Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Session: Clinical news in idiopathic interstitial pneumonias
Session type: Oral Presentation
Number: 540
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Wung (Bridgewater, United States of America), G. Raghu (Seattle, United States of America), B. Crestani (Paris, France), L. Richeldi (Rome, Italy), C. Esperet (Paris, France), C. Soubrane (Paris, France). Late Breaking Abstract - Prevalence and clinical significance of antinuclear antibody (ANA) in IPF: analysis from ESTAIR study. 540

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: